Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
about
Selection for hepatic resection of colorectal liver metastases: expert consensus statementRadiation risks associated with serial imaging in colorectal cancer patients: should we worry?The uses and limitations of whole-body magnetic resonance imaging.Use of computed tomography in the management of colorectal cancer.Colorectal hepatic metastasis: Evolving therapies.BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.Detection of resectable recurrences in colorectal cancer patients with 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomographyImaging as a surveillance tool in rectal cancer.Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challengesAn outlook on future design of hybrid PET/MRI systems.Local colorectal cancer recurrence: pelvic MRI evaluation.Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review.Evidence-based medicine and clinical fluorodeoxyglucose PET/MRI in oncology.Pre-operative staging of rectal cancer: a review of imaging techniques.False-Positive Mediastinal Lymphadenopathy on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography after Rectal Cancer Resection: A Case Report of Thoracoscopic Surgery in the Prone Position.Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.Association between carcinoembryonic antigen levels and the applied value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative recurrent and metastatic colorectal cancer.Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis.Whole-body 18FDG-PET/CT or whole-body gadolinium-enhanced MRI for distant staging?The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.Comparison of hybrid FDG PET/MRI compared with PET/CT in colorectal cancer staging and restaging: a pilot study.[Importance of whole body MRI for staging of colorectal cancer].[Importance of PET/CT for imaging of colorectal cancer].PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.
P2860
Q30415026-669592B2-8A32-496C-B797-A7CE8F512FA5Q30444573-9F3CE9F7-7690-4F26-A62D-E98E99170B48Q33931426-47C0BEBE-704C-42D0-B3B4-65D167E94EE2Q34390519-DDD77D8F-75D2-4316-BB32-9FC94641B358Q34663557-BE002E58-3C93-4EAD-B2E9-664A05D50B93Q36086837-EADB50F8-F2D0-4904-B082-5B744BFC14AFQ37025733-ECF4EC7D-8480-4205-9C16-CA0CB4A8B25AQ37658819-401DD151-922E-4AFB-82D8-EBAC4D95CBDAQ37695249-EEF4EEE3-208F-43A7-A295-6FEEA91FA5E1Q37944879-F8081222-167D-45FD-9F7D-BE61EBE25E26Q38000904-2B80C0C6-3673-42DB-9E90-20150F50906EQ38153365-5E3ECF5F-DE5F-4978-BC5A-572C5206770AQ38636452-838BE5C9-CB62-4FF0-90B9-F496435A5467Q38827538-23E65023-4DEF-4185-AD2B-C0B7FFD2B176Q40157447-CA5CC219-7594-447E-B660-F9DEB5FECD3AQ40679974-63A12623-4AEA-4664-BDDB-2CC2B47DAD67Q42587608-FB3256E8-3CA8-4918-841C-AFEC85DDC03CQ42780962-4DA0CF75-19E5-45D0-881E-A76A73E172CDQ42968874-0ABA0C76-E3B5-493C-94A3-8A946FC059C0Q45736731-D6ADF968-63C9-40ED-A58E-3F765174C1BEQ46014390-4F5522A2-1577-4D06-973B-06E9A5124F1BQ47850746-3E3836E9-91E6-4BC0-A5CB-B5EF993D18B0Q53000730-F5F248E9-AB5C-4FB5-A53C-F2ECF65683C4Q53100009-49E9FF3D-9F40-4306-97D0-322874F6257CQ53160436-700D8C52-D531-4FA8-AAA3-B53FF563324CQ53243977-DD2640E4-8595-487C-9296-3003950F5380
P2860
Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Whole-body MRI at 1.5 T and 3 ...... tients with colorectal cancer.
@en
Whole-body MRI at 1.5 T and 3 ...... tients with colorectal cancer.
@nl
type
label
Whole-body MRI at 1.5 T and 3 ...... tients with colorectal cancer.
@en
Whole-body MRI at 1.5 T and 3 ...... tients with colorectal cancer.
@nl
prefLabel
Whole-body MRI at 1.5 T and 3 ...... tients with colorectal cancer.
@en
Whole-body MRI at 1.5 T and 3 ...... tients with colorectal cancer.
@nl
P2093
P2860
P1433
P1476
Whole-body MRI at 1.5 T and 3 ...... tients with colorectal cancer.
@en
P2093
A Baur-Melnyk
C R Becker
G P Schmidt
K A Hermann
M F Reiser
S Utzschneider
P2860
P2888
P304
P356
10.1007/S00330-008-1289-Y
P407
P577
2009-02-04T00:00:00Z